EU Healthcare and Pharmaceutical Policy in 2023: What You Need to Know

From the ongoing revision of the EU pharmaceutical legislation package and addressing critical supply issues to the impact of the recent Medical Device Regulation transition period extension, the challenges in EU healthcare and pharmaceutical policy are ever-evolving. Plus, with the implementation of critical files, such as the European Health Data Space (EHDS) and the Substances of Human Origin (SoHo) regulation, it’s vital for organizations in this market to stay up-to-date with the latest policy and regulatory developments.

Tune in on May 17 at 4 pm CEST | 10 am EDT for a 30-minute recorded webinar that will delve into the latest updates in legislation and regulation that are shaping the future of healthcare, pharmaceutical, and medical device industries in Europe to help you navigate the next steps in this policy landscape.

Experts will discuss:

• The ongoing revision of EU pharmaceutical legislation
• Tackling critical supply issues in pharmaceuticals and medical devices
• The impact of the Medical Device Regulation transition period extension
• Proposed and upcoming critical files you should be monitoring
• The future of EU healthcare policy in 2023 and beyond

Featured speakers:

• Adrien Samson, healthcare policy & public affairs senior manager, EuropaBio
• Jelle Verheij, policy analyst – health and pharmaceuticals policy, EU Issue Tracker
• Moderator: Geraint Edwards, managing director of FiscalNote Brussels